Literature DB >> 34990263

Dynamic contrast-enhanced breast magnetic resonance imaging findings that affect the magnetic resonance-directed ultrasound correlation of non-mass enhancement lesions: a single-center retrospective study.

Almila Coskun Bilge1, Pinar Ilhan Demir2, Hale Aydin3, Isil Esen Bostanci1.   

Abstract

OBJECTIVE: Our single-center retrospective study aimed to evaluate the relationship between magnetic resonance (MR)-directed ultrasound (MDUS) detectability and MRI findings of non-mass enhancement (NME) lesions, regarding the morphologic and enhancement features, the distance from the skin and nipple, and the presence of concomitant landmarks.
METHODS: A total of 350 MRI-detected NME lesions that were determined between January 2015 and May 2019 and subsequently underwent MDUS were analyzed. The MRI findings, biopsy results, and follow-up outcomes of lesions were recorded. The correlation between the MRI findings of the lesions and MDUS detectability was analyzed.
RESULTS: 114 (32.6%) of the 350 lesions had a counterpart in the MDUS. Respectively, 66 (37.9%), 38 (43.2%) and 59 (38.3%) of the lesions detected in MDUS were larger than 20 mm in size, with a distance of less than 20 mm to the nipple and 15 mm to the skin. The lesion size and lesion distance to the nipple and skin were significantly associated with a ultrasound correlate (p < 0.05). The MDUS detection rate was significantly higher in NME lesions with MR findings including diffuse distribution (p < 0.001), clustered-ring enhancement pattern (p < 0.001), washout kinetic curve (p = 0.006), and MR-BIRADS category 5 (p < 0.001). Multivariate logistic regression showed that only the clustered-ring enhancement pattern was significantly associated with an MDUS correlation (p < 0.001).
CONCLUSION: Statistically significant correlations were found between the size, distance to the nipple and skin, distribution pattern, enhancement pattern and kinetic curve of the NME lesions on MRI and ultrasound detectability. ADVANCES IN KNOWLEDGE: We found that clustered-ring enhancement patterns were significantly more frequent in MR-directed ultrasound detectable lesions.

Entities:  

Mesh:

Year:  2022        PMID: 34990263      PMCID: PMC9153717          DOI: 10.1259/bjr.20210832

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.629


  37 in total

Review 1.  Ductal carcinoma in situ of the breasts: review of MR imaging features.

Authors:  Heather I Greenwood; Samantha L Heller; Sungheon Kim; Eric E Sigmund; Sara D Shaylor; Linda Moy
Journal:  Radiographics       Date:  2013-10       Impact factor: 5.333

2.  Second-look US: how to find breast lesions with a suspicious MR imaging appearance.

Authors:  Vivian Youngjean Park; Min Jung Kim; Eun-Kyung Kim; Hee Jung Moon
Journal:  Radiographics       Date:  2013 Sep-Oct       Impact factor: 5.333

3.  Nonmasslike enhancement at breast MR imaging: the added value of mammography and US for lesion categorization.

Authors:  Isabelle Thomassin-Naggara; Isabelle Trop; Jocelyne Chopier; Julie David; Lucie Lalonde; Emile Darai; Roman Rouzier; Serge Uzan
Journal:  Radiology       Date:  2011-07-19       Impact factor: 11.105

4.  Can we predict lesion detection rates in second-look ultrasound of MRI-detected breast lesions? A systematic analysis.

Authors:  Alexander Bumberger; Paola Clauser; Michael Kolta; Panagiotis Kapetas; Maria Bernathova; Thomas H Helbich; Katja Pinker; Pascal A Baltzer
Journal:  Eur J Radiol       Date:  2019-02-11       Impact factor: 3.528

5.  Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC).

Authors:  Sepideh Saadatmand; Inge-Marie Obdeijn; Emiel J Rutgers; Jan C Oosterwijk; Rob A Tollenaar; Gwendolyn H Woldringh; Elisabeth Bergers; Cornelis Verhoef; Eveline A Heijnsdijk; Maartje J Hooning; Harry J de Koning; Madeleine M Tilanus-Linthorst
Journal:  Int J Cancer       Date:  2015-04-17       Impact factor: 7.396

6.  Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer.

Authors:  Christiane K Kuhl; Kevin Strobel; Heribert Bieling; Claudia Leutner; Hans H Schild; Simone Schrading
Journal:  Radiology       Date:  2017-02-21       Impact factor: 11.105

Review 7.  Background parenchymal enhancement on breast MRI: A comprehensive review.

Authors:  Geraldine J Liao; Leah C Henze Bancroft; Roberta M Strigel; Rhea D Chitalia; Despina Kontos; Linda Moy; Savannah C Partridge; Habib Rahbar
Journal:  J Magn Reson Imaging       Date:  2019-04-19       Impact factor: 4.813

8.  Categorization of non-mass-like breast lesions detected by MRI.

Authors:  Naomi Sakamoto; Mitsuhiro Tozaki; Kuniki Higa; Yuko Tsunoda; Tomoko Ogawa; Satoko Abe; Shinji Ozaki; Masaaki Sakamoto; Tomoko Tsuruhara; Naoko Kawano; Takako Suzuki; Norie Yamashiro; Eisuke Fukuma
Journal:  Breast Cancer       Date:  2008-01-22       Impact factor: 4.239

9.  Interobserver variability and likelihood of malignancy for fifth edition BI-RADS MRI descriptors in non-mass breast lesions.

Authors:  Magdalena Lunkiewicz; Serafino Forte; Bianka Freiwald; Gad Singer; Cornelia Leo; Rahel A Kubik-Huch
Journal:  Eur Radiol       Date:  2019-08-07       Impact factor: 5.315

10.  Association of Different MRI BIRADS Descriptors With Malignancy in Non Mass-Like Breast Lesions.

Authors:  Masoumeh Gity; Koosha Ghazi Moghadam; Amir Hossein Jalali; Madjid Shakiba
Journal:  Iran Red Crescent Med J       Date:  2014-12-30       Impact factor: 0.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.